Together with a preceding report describing the biallelic loss of BRCA1 in a young ovarian cancer patient with multiple congenital abnormalities (Domchek et al., 2013), this proof contributed to the identification of BRCA1 as FANCS. This evidence concerns the gene BRCA1 and ovarian carcinoma.